CAD106 and CNP520 to Prevent or Delay Symptoms of Alzheimer's Disease
Language
Undefined
Purpose: To test whether two investigational drugs, CAD106 and CNP520, can prevent or delay Alzheimer's symptoms in people at high risk.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: chirschman Source Type: clinical trials